Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Sundry Debtors

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Sundry Debtors ₹848 Cr₹576 Cr₹388 Cr₹331 Cr₹531 Cr

What is the latest Sundry Debtors ratio of MANKIND PHARMA ?

The latest Sundry Debtors ratio of MANKIND PHARMA is ₹848 Cr based on Mar2024 Consolidated results.
Year Sundry Debtors
Mar2024₹848 Cr
Mar2023₹576 Cr
Mar2022₹388 Cr
Mar2021₹331 Cr
Mar2020₹531 Cr

How is Sundry Debtors of MANKIND PHARMA Trending?

Years Sundry Debtors % Change
Mar2024 ₹848 Cr
47.16
Mar2023 ₹576 Cr
48.50
Mar2022 ₹388 Cr
17.41
Mar2021 ₹331 Cr
-37.75
Mar2020 ₹531 Cr -

Compare Sundry Debtors of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹98,303.1 Cr 1.1% -7% 9.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,176.0 Cr -0.3% -2.9% 11.5% Stock Analytics
DIVIS LABORATORIES ₹177,076.0 Cr 0.7% 7.4% 48.1% Stock Analytics
CIPLA ₹121,592.0 Cr -0.1% 0.2% -2.1% Stock Analytics
DR REDDYS LABORATORIES ₹113,615.0 Cr 3.2% 10.3% 11.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,024.0 Cr 2.3% -0.5% 13.8% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.1%

-7%

9.7%

SENSEX

-1.3%

-0.3%

5.8%


You may also like the below Video Courses